Neurogel en Marche is planning clinical trials to treat people who are handicapped as a result of a spinal cord injury. As a quick reminder, Neurogel is a synthetic gel that plays the role of a growth matrix that facilitates the re-connection of the nerve fibers from the brain to the limbs.

Since Neurogel's technological cluster could benefit not only people suffering from paralysis, but people with head trauma, spina-bifida, brain tumors or optical nerve lesions, the implications are enormous.
To make sure we can include our volunteer patients, we must be help fund this project.
Please keep in mind that no amount is too small; your donation will be a precious gift to those who are confined to a wheelchair.

Next

December 09, 2009

Video of our October 29 & 30 meeting at the Institute of Experimental Research of the Academy of Sciences of Prague, Czech Republic. The purpose of the meeting was to redefine the modalities and requirements of a human trial.

View the video now

New !

Dear members,

May 25, we met with the French Agency of Sanitary Safety and Health Products, AFSSAPS. As you know, this was a necessary step towards an application for a clinical trial in France.

Talks centered mainly on clinical regulations, the manufacture of Neurogel, pre-clinical trials, and toxicology tests ; we also discussed ways in which AFSSAPS can support us, including in our attempts to seek funding, within the framework of their research and innovation services.

Since the meeting in Prague, we have been working on conducting a multi-center clinical trial, which is now taking shape. Several medical centers are interested in our project..

Next